Black Rock Inc. Altimmune, Inc. Transaction History

Black Rock Inc.

$4.35 Trillion
Q2 2024

A detailed history of Black Rock Inc. transactions in Altimmune, Inc. stock. As of the latest transaction made, Black Rock Inc. holds 5,321,089 shares of ALT stock, worth $35.9 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

5,321,089

Previous 4,042,226 31.64%

Holding current value

$35.9 Million

Previous $41.1 Million 14.01%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$5.91 - $10.23 $7.56 Million - $13.1 Million	1,278,863 Added 31.64%	5,321,089 $35.4 Million
Q1 2024 May 10, 2024	SELL	$8.22 - $13.81 $20,393 - $34,262	-2,481 Reduced 0.06%	4,042,226 $41.1 Million
Q4 2023 Feb 13, 2024	BUY	$2.14 - $11.62 $551,672 - $3 Million	257,791 Added 6.81%	4,044,707 $45.5 Million
Q3 2023 Nov 13, 2023	BUY	$2.4 - $3.45 $294,340 - $423,114	122,642 Added 3.35%	3,786,916 $9.85 Million
Q2 2023 Aug 11, 2023	BUY	$3.45 - $5.97 $7.83 Million - $13.6 Million	2,270,219 Added 162.85%	3,664,274 $12.9 Million
Q1 2023 May 12, 2023	BUY	$4.19 - $16.83 $167,692 - $673,570	40,022 Added 2.96%	1,394,055 $5.88 Million
Q4 2022 Feb 13, 2023	BUY	$8.74 - $16.45 $1.18 Million - $2.22 Million	134,733 Added 11.05%	1,354,033 $22.3 Million
Q3 2022 Nov 14, 2022	BUY	$10.67 - $22.41 $2.74 Million - $5.76 Million	257,116 Added 26.72%	1,219,300 $15.6 Million
Q2 2022 Aug 12, 2022	SELL	$3.94 - $11.77 $7.78 Million - $23.2 Million	-1,974,140 Reduced 67.23%	962,184 $11.3 Million
Q1 2022 May 12, 2022	SELL	$5.9 - $9.45 $117,663 - $188,461	-19,943 Reduced 0.67%	2,936,324 $17.9 Million
Q4 2021 Feb 10, 2022	BUY	$8.69 - $12.48 $125,805 - $180,672	14,477 Added 0.49%	2,956,267 $27.1 Million
Q3 2021 Nov 09, 2021	BUY	$8.43 - $16.81 $3.24 Million - $6.46 Million	384,548 Added 15.04%	2,941,790 $33.3 Million
Q2 2021 Aug 11, 2021	BUY	$9.85 - $16.46 $25.2 Million - $42.1 Million	2,557,242 New	2,557,242 $25.2 Million

Others Institutions Holding ALT

# of Institutions

189

Shares Held

42.3M

Call Options Held

1.05M

Put Options Held

582K

View Full List

About Altimmune, Inc.

Ticker ALT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 49,025,300
Market Cap $330M
Description
Altimmune, Inc., a clinical stage biopharmaceutical company, focuses on developing treatments for obesity and liver diseases. The company's lead product candidate, pemvidutide (proposed INN, formerly known as ALT-801), is a GLP-1/glucagon dual receptor agonist that is in Phase 1b trial for the treatment of obesity and non-alcoholic steatohepatit...

More about ALT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

News

Stay updated on Black Rock Inc. with notifications on news.

Account